Table 3 Top 10 most cited WoS papers
From: Global informetric perspective studies on translational medical research
No. | Time cited | Authors | Title | Journal | Institute | Country | Year |
|---|---|---|---|---|---|---|---|
1 | 111 | Woolf Steven H. | The meaning of translational research and why it matters | JAMA | Virginia Commonwealth University | USA | 2008 |
2 | 102 | Sung, NS; Crowley, WF; Genel, M; et al. | Central challenges facing the national clinical research enterprise | JAMA | Burroughs Wellcome Fund | USA | 2003 |
3 | 66 | Zerhouni, EA | Translational and clinical science - Time for a new vision | New EnglandJournal of Medicine | National Institutes of Health | USA | 2005 |
4 | 65 | Zerhouni, EA | The NIH roadmap | Science | National Institutes of Health | USA | 2003 |
5 | 60 | Westfall, JM; Mold, J; Fagnan, L | Practice-based research - “Blue Highways” on the NIH roadmap | JAMA | University of Colorado Health Sciences Center | USA | 2007 |
6 | 53 | Hanahan, D; Weinberg, RA | The hallmarks of cancer | Cell | University of California, San Francisco | USA | 2000 |
7 | 46 | van de Vijver, MJ; He, YD; van ’t Veer, LJ; et al. | A gene-expression signature as a predictor of survival in breast cancer. | New EnglandJournal of Medicine | Netherlands Cancer Institute | Netherlands | 2002 |
8 | 44 | Marincola FM | Translational medical research: A two-way road | Journal of Translational medical research | National Institutes of Health | USA | 2003 |
9 | 41 | Khoury, MJ; Gwinn, M; Yoon, PW; et al. | The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? | Genetics in Medicine | National Office of Public Health Genomics Centers for Disease Control and Prevention | USA | 2007 |
10 | 40 | van’t Veer, LJ; Dai, HY; van de Vijver, MJ; et al. | Gene expression profiling predicts clinical outcome of breast cancer | Nature | Rosetta Inpharmat, Kirkland | USA | 2002 |
10 | 40 | Paez, JG; Janne, PA; Lee, JC; et al. | EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy | Science | Departments of Medical Oncology and Cancer Biology, Dana-Farber Cancer Institute | USA | 2004 |